Don't Jump to Ubrelvy or Reyvow for Acute Migraine Treatment
March 2020
You'll see new oral meds to treat acute migraine in adults, Ubrelvy (yoo-BREL-vee, ubrogepant) and Reyvow (RAY-vow, lasmiditan).
Ubrelvy is the first "gepant." It blocks receptors of calcitonin gene-related peptide (CGRP), a vasodilator and pain sensitizer that spikes during migraine attacks.
It's different than the injectables for PREVENTION (Aimovig, Ajovy, Emgality)...monoclonal antibodies that block CGRP effects.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote